Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Jan Best"'
Autor:
Alexander Bellendorf, Nicolai Mader, Stefan P. Mueller, Samer Ezziddin, Andreas Bockisch, Hong Grafe, Jan Best, Juliane Goebel, Thorsten D. Pöppel, Amir Sabet
Publikováno v:
Pharmaceuticals, Vol 17, Iss 1, p 101 (2024)
Transarterial chemoembolization (TACE) is currently the standard of care in patients with unresectable hepatocellular carcinoma (HCC), and selective internal radionuclide therapy (SIRT) with 90Y microspheres is mainly used as an alternative modality
Externí odkaz:
https://doaj.org/article/ce066bddbbfe4070ba50e46d4695e908
Autor:
Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, Jan Best, Thorben Wilhelm Fründt, Carolin Czauderna, Alica Beutel, Dominik Bettinger, Johannes Weiß, Tobias Meischl, Fabian Kütting, Dirk-Thomas Waldschmidt, Pompilia Radu, Michael Schultheiß, Kai-Henrik Peiffer, Thomas J. Ettrich, Arndt Weinmann, Henning Wege, Marino Venerito, Jean-Francois Dufour, Christian M. Lange, Matthias Pinter, Oliver Waidmann
Publikováno v:
Liver Cancer, Pp 1-10 (2021)
Background and Aims: The multikinase inhibitor cabozantinib has been approved for hepatocellular carcinoma (HCC) previously treated with sorafenib. We report safety and efficacy data of an international, multicenter, real-life cohort of patients with
Externí odkaz:
https://doaj.org/article/49aa2979d981472fba28858c369ad697
Autor:
Jan Best, Lars P. Bechmann
Publikováno v:
EBioMedicine, Vol 74, Iss , Pp 103711- (2021)
Externí odkaz:
https://doaj.org/article/6bf08e17cf1444358d29e712e207ffc9
Autor:
Joeri Lambrecht, Stefaan Verhulst, Inge Mannaerts, Jan-Peter Sowa, Jan Best, Ali Canbay, Hendrik Reynaert, Leo A. van Grunsven
Publikováno v:
EBioMedicine, Vol 43, Iss , Pp 501-512 (2019)
Background: Platelet Derived Growth Factor Receptor beta (PDGFRβ) has been associated to hepatic stellate cell activation and has been the target of multiple therapeutic studies. However, little is known concerning its use as a diagnostic agent. Met
Externí odkaz:
https://doaj.org/article/5f85e40af5a64303a768e25e13006a94
Autor:
Sabrina Welland, Catherine Leyh, Fabian Finkelmeier, André Jefremow, Kateryna Shmanko, Maria A. Gonzalez-Carmona, Arne Kandulski, Petia Jeliazkova, Jan Best, Thorben W. Fründt, Angela Djanani, Maria Pangerl, Andreas Maieron, Richard Greil, Christina Fricke, Disorn Sookthai, Rainer Günther, Andreas Schmiderer, Henning Wege, Marino Venerito, Ursula Ehmer, Martina Müller, Christian P. Strassburg, Arndt Weinmann, Jürgen Siebler, Oliver Waidmann, Christian M. Lange, Anna Saborowski, Arndt Vogel
Publikováno v:
Liver Cancer, p 1 (2022)
Background Lenvatinib is approved as first-line treatment for patients with advanced hepatocellular carcinoma (HCC). The efficacy of lenvatinib in Caucasian real-world patients is insufficiently defined. The purpose of this study was to evaluate the
Externí odkaz:
https://doaj.org/article/8a92700df3fd4606aa03d07ae73baa60
Autor:
Paul Manka, Svenja Sydor, Julia M. Schänzer-Ocklenburg, Malte Brandenburg, Jan Best, Ramiro Vilchez-Vargas, Alexander Link, Dominik Heider, Susanne Brodesser, Anja Figge, Andreas Jähnert, Jason D. Coombes, Francisco Javier Cubero, Alisan Kahraman, Moon-Sung Kim, Julia Kälsch, Sonja Kinner, Klaas Nico Faber, Han Moshage, Guido Gerken, Wing-Kin Syn, Ali Canbay, Lars P. Bechmann
Publikováno v:
Metabolites, Vol 12, Iss 2, p 130 (2022)
Celiac disease (CeD) is a chronic autoimmune disorder characterized by an intolerance to storage proteins of many grains. CeD is frequently associated with liver damage and steatosis. Bile acid (BA) signaling has been identified as an important media
Externí odkaz:
https://doaj.org/article/a1b2e659cb3f497f8131bc8f7dae41a1
Autor:
Clemens Schotten, Bastian Ostertag, Jan-Peter Sowa, Paul Manka, Lars P. Bechmann, Gudrun Hilgard, Claudio Marquardt, Marc Wichert, Hidenori Toyoda, Christian M. Lange, Ali Canbay, Philip Johnson, Heiner Wedemeyer, Jan Best
Publikováno v:
Pharmaceuticals, Vol 14, Iss 8, p 735 (2021)
Despite vaccination programs and direct antiviral treatments, the incidence of virus-related hepatocellular carcinoma (HCC) remains high, while ultrasound-based detection rates for early-stage HCC is continuously low. To address this insufficiency, w
Externí odkaz:
https://doaj.org/article/045468dca41d475ab6d9de7bf5362464
Autor:
Svenja Sydor, Paul Manka, Jan Best, Sami Jafoui, Jan-Peter Sowa, Miguel Eugenio Zoubek, Virginia Hernandez-Gea, Francisco Javier Cubero, Julia Kälsch, Diana Vetter, Maria Isabel Fiel, Yujin Hoshida, C. Billie Bian, Leonard J. Nelson, Han Moshage, Klaas Nico Faber, Andreas Paul, Hideo A. Baba, Guido Gerken, Scott L. Friedman, Ali Canbay, Lars P. Bechmann
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Abstract Krüppel-like factor 6 (KLF6) is a transcription factor and tumor suppressor. We previously identified KLF6 as mediator of hepatocyte glucose and lipid homeostasis. The loss or reduction of KLF6 is linked to the progression of hepatocellular
Externí odkaz:
https://doaj.org/article/2286249dec7344db8e423965de3b8b26
Publikováno v:
Liver Cancer, Pp 1-2 (2020)
Externí odkaz:
https://doaj.org/article/3037136e82aa4b33b4141627194bc6bb
Autor:
Jan Best, Andreas Zahn, Anja Beilfuß, Svenja Sydor, Christian Fingas, Jan-Peter Sowa, Olympia Anastasiou, Vito Cicinnati, Guido Gerken, Ali Canbay, Lars P. Bechmann
Publikováno v:
Annals of Hepatology, Vol 14, Iss 3, Pp 396-403 (2015)
Introduction. Hepatitis C virus (HCV) infection is an important risk factor for the development of liver fibrosis and progression to cirrhosis. Liver transplantation as terminal treatment option for liver disease requires life-long immunosuppression.
Externí odkaz:
https://doaj.org/article/a3212cf61c04472a8a0007cca86a1b95